With AI-BIO

PIPELINE

Pipeline

Baobab AiBIO Pipeline

Drug Repositioning

New Chemical Entity

Large Molecule

Status Program Target Disease Exploratory Research IND Enabling Early Clinical Late Clinical Milestone/Issue
Active BAB-104 MSTO, GBM arrow02         IND in 4Q 2023
BAB-107 mCRC arrow03         in Vivo tool 4Q 2022
BAB-201 Fibrosis arrow04         Collaboration
BAB-202 RA arrow05         Collaboration
BAB-301 Parkinson arrow06         Hit 2Q 2022
BAB-802 Antibody arrow07         Collaboration
BAB-803 Fibrosis arrow09         Collaboration
Basic
Study
BAB-103 CRC, NSCLC arrow09         Properties improvement
BAB-105 Breast Cancer arrow10         Collaboration
BAB-106 Cancer metastasis arrow11         Collaboration
Undisclosed immuno Oncology arrow03         structure 1Q 2022
Undisclosed Fibrosis arrow03         structure 2Q 2022